Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes

Diabetologia

Volumn 54, Issue 7, 2011, Pages 1841-1852

  Skrzypski, M ^a,b   Le, T T ^a   Kaczmarek, P ^b   Pruszynska Oszmalek, E ^b   Pietrzak, P ^c   Szczepankiewicz, D ^b   Kolodziejski, P A ^b   Sassek, M ^b   Arafat, A ^a,d   Wiedenmann, B ^a   Nowak, K W ^b   Strowski, M Z ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^c WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

G protein coupled receptor; In vitro; Lipids; Obesity; Orexin; Secretion

Indexed keywords

ADIPONECTIN; GLUCOSE TRANSPORTER 4; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; DRUG BLOOD LEVEL; FIBROBLAST; GENE EXPRESSION; GLUCOSE TRANSPORT; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 85027940075     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2152-2     Document Type: Article

References (40)

1. T Sakurai A Amemiya M Ishii, et al. 1998 Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 92 573 585 9491897 10.1016/S0092-8674(00)80949-6 1:CAS:528:DyaK1cXhsVKntr4%3D (Pubitemid 28101119)
2. J Hara CT Beuckmann T Nambu, et al. 2001 Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity Neuron 30 345 354 11394998 10.1016/S0896-6273(01)00293-8 1:CAS:528:DC%2BD3MXktFeisbc%3D (Pubitemid 32530580)
3. J Hara M Yanagisawa T Sakurai 2005 Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions Neurosci Lett 380 239 242 15862893 10.1016/j.neulet.2005.01.046 1:CAS:528:DC%2BD2MXjvVOgt70%3D (Pubitemid 40616087)
4. H Funato AL Tsai JT Willie, et al. 2009 Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity Cell Metab 9 64 76 19117547 10.1016/j.cmet.2008.10.010 1:CAS:528: DC%2BD1MXptFajsw%3D%3D
5. S Nishino B Ripley S Overeem GJ Lammers E Mignot 2000 Hypocretin (orexin) deficiency in human narcolepsy Lancet 355 39 40 10615891 10.1016/S0140-6736(99) 05582-8 1:CAS:528:DC%2BD3cXnt1Cqsg%3D%3D (Pubitemid 30072183)
6. S Nishino B Ripley S Overeem, et al. 2001 Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy Ann Neurol 50 381 388 11558795 10.1002/ana.1130 1:CAS:528:DC%2BD3MXntFalt7s%3D (Pubitemid 32848741)
7. Y Honda Y Doi R Ninomiya C Ninomiya 1986 Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients Sleep 9 254 259 3518018 1:STN:280:DyaL283gslGrug%3D%3D (Pubitemid 18008505)
8. JA Adam PP Menheere FM van Dielen PB Soeters WA Buurman JW Greve 2002 Decreased plasma orexin-A levels in obese individuals Int J Obes Relat Metab Disord 26 274 276 11850761 10.1038/sj.ijo.0801868 1:CAS:528:DC%2BD38XitVClsLk%3D (Pubitemid 34151207)
9. M Nakabayashi T Suzuki K Takahashi, et al. 2003 Orexin-A expression in human peripheral tissues Mol Cell Endocrinol 205 43 50 12890566 10.1016/S0303-7207(03)00206-5 1:CAS:528:DC%2BD3sXlvVSks74%3D (Pubitemid 37297350)
10. M Ehrstrom E Naslund F Levin, et al. 2004 Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat Regul Pept 119 209 212 15120482 10.1016/j.regpep.2004.02.004 1:CAS:528:DC%2BD2cXjs1aqsLg%3D (Pubitemid 38553839)
11. R Ouedraogo E Naslund AL Kirchgessner 2003 Glucose regulates the release of orexin-a from the endocrine pancreas Diabetes 52 111 117 12502500 10.2337/diabetes.52.1.111 1:CAS:528:DC%2BD3sXisVaisQ%3D%3D (Pubitemid 36042114)
12. MM Switonska P Kaczmarek LK Malendowicz KW Nowak 2002 Orexins and adipoinsular axis function in the rat Regul Pept 104 69 73 11830279 10.1016/S0167-0115(01)00350-0 1:CAS:528:DC%2BD38XhtVKlsLo%3D (Pubitemid 34119375)
13. E Goncz MZ Strowski C Grotzinger, et al. 2008 Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway Endocrinology 149 1618 1626 18162514 10.1210/en.2007-1257 (Pubitemid 351468335)
14. KW Nowak MZ Strowski MM Switonska, et al. 2005 Evidence that orexins A and B stimulate insulin secretion from rat pancreatic islets via both receptor subtypes Int J Mol Med 15 969 972 15870901 1:CAS:528:DC%2BD2MXltFSitL0%3D
15. H Tsuneki Y Sugihara R Honda T Wada T Sasaoka I Kimura 2002 Reduction of blood glucose level by orexins in fasting normal and streptozotocin-diabetic mice Eur J Pharmacol 448 245 252 12144948 10.1016/S0014-2999(02)01936-2 1:CAS:528:DC%2BD38Xls1Wrsb0%3D (Pubitemid 34874594)
16. H Tsuneki S Murata Y Anzawa, et al. 2008 Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice Diabetologia 51 657 667 18256806 10.1007/s00125-008-0929-8 1:CAS:528:DC%2BD1cXjsFGiu70%3D
17. K Zwirska-Korczala M Mczyk-Sowa P Sowa, et al. 2007 Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism J Physiol Pharmacol 58 Suppl 1 53 64 (Pubitemid 350022258)
18. JE Digby J Chen JY Tang H Lehnert RN Matthews HS Randeva 2006 Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B J Endocrinol 191 129 136 17065396 10.1677/joe.1.06886 1:CAS:528:DC%2BD28Xht1eju7nL (Pubitemid 44756515)
19. D Sikder T Kodadek 2007 The neurohormone orexin stimulates hypoxia-inducible factor-1 activity Genes Dev 21 2995 3005 18006690 10.1101/gad.1584307 1:CAS:528:DC%2BD2sXhtlGmsrnI (Pubitemid 350133445)
20. J Berger M Tanen A Elbrecht, et al. 2001 Peroxisome proliferator- activated receptor-gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity J Biol Chem 276 12629 12635 11278270 10.1074/jbc.M003592200 1:CAS:528:DC%2BD3MXjtFynt7k%3D
21. M Rodbell 1964 Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis J Biol Chem 239 375 380 14169133 1:CAS:528:DyaF2cXjt1GhsQ%3D%3D
22. C Nugent JB Prins JP Whitehead, et al. 2001 Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation Mol Endocrinol 15 1729 1738 11579205 10.1210/me.15.10.1729 1:CAS:528:DC%2BD3MXnt12isb0%3D (Pubitemid 32939303)
23. S Tang H Le-Tien BJ Goldstein P Shin R Lai IG Fantus 2001 Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes Diabetes 50 83 90 11147799 10.2337/diabetes.50.1.83 1:CAS:528:DC%2BD3MXis1OntA%3D%3D (Pubitemid 32047985)
24. A Gray H Olsson IH Batty L Priganica DC Peter 2003 Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts Anal Biochem 313 234 245 12605860 10.1016/S0003-2697(02)00607-3 1:CAS:528: DC%2BD3sXhsVChtrY%3D (Pubitemid 36259947)
25. T Szkudelski K Szkudelska L Nogowski 2009 Effects of adenosine A1 receptor antagonism on lipogenesis and lipolysis in isolated rat adipocytes Physiol Res 58 863 871 19093734 1:CAS:528:DC%2BC3cXitVWjtLw%3D
26. VP Dole H Meinertz 1960 Microdetermination of long-chain fatty acids in plasma and tissues J Biol Chem 235 2595 2599 13817286 1:CAS:528: DyaF3cXht12qurg%3D
27. R Somwar W Niu DY Kim, et al. 2001 Differential effects of phosphatidylinositol 3-kinase inhibition on intracellular signals regulating GLUT4 translocation and glucose transport J Biol Chem 276 46079 46087 11598141 10.1074/jbc.M109093200 1:CAS:528:DC%2BD3MXptVymsbY%3D
28. E van de Wall R Leshan AW Xu, et al. 2008 Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion Endocrinology 149 1773 1785 18162515 10.1210/en.2007-1132 (Pubitemid 351468315)
29. X Xia G Serrero 1999 Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors J Cell Physiol 178 9 16 9886485 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-# 1:CAS:528:DyaK1cXnvFKgs78%3D (Pubitemid 28554917)
30. P Tontonoz E Hu RA Graves AI Budavari BM Spiegelman 1994 mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer Genes Dev 8 1224 1234 7926726 10.1101/gad.8.10.1224 1:CAS:528:DyaK2cXlsFSgsbc%3D
31. J Auwerx K Schoonjans JC Fruchart B Staels 1996 Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects J Atheroscler Thromb 3 81 89 9226459 1:CAS:528:DyaK2sXktlWns7w%3D
32. J Rieusset F Andreelli D Auboeuf, et al. 1999 Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes Diabetes 48 699 705 10102684 10.2337/diabetes.48.4.699 1:CAS:528:DyaK1MXitFCqtrk%3D (Pubitemid 29153067)
33. BM Spiegelman 1998 PPAR-gamma: adipogenic regulator and thiazolidinedione receptor Diabetes 47 507 514 9568680 10.2337/diabetes.47.4.507 1:CAS:528:DyaK1cXit1Gnsrk%3D (Pubitemid 28160438)
34. V Giusti C Verdumo M Suter RC Gaillard P Burckhardt F Pralong 2003 Expression of peroxisome proliferator-activated receptor-gamma1 and peroxisome proliferator-activated receptor-gamma2 in visceral and subcutaneous adipose tissue of obese women Diabetes 52 1673 1676 12829631 10.2337/diabetes.52.7.1673 1:CAS:528:DC%2BD3sXltlWhtLw%3D (Pubitemid 36792455)
35. J Zhang M Fu T Cui, et al. 2004 Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity Proc Natl Acad Sci USA 101 10703 10708 15249658 10.1073/pnas.0403652101 1:CAS:528: DC%2BD2cXmtFWmtrY%3D (Pubitemid 38955806)
36. PM Turunen ME Ekholm P Somerharju JP Kukkonen 2010 Arachidonic acid release mediated by OX1 orexin receptors Br J Pharmacol 159 212 221 20002100 10.1111/j.1476-5381.2009.00535.x 1:CAS:528:DC%2BC3cXhtFyntL4%3D
37. HM Peltonen JM Magga G Bart, et al. 2009 Involvement of TRPC3 channels in calcium oscillations mediated by OX(1) orexin receptors Biochem Biophys Res Commun 385 408 412 19464259 10.1016/j.bbrc.2009.05.077 1:CAS:528: DC%2BD1MXnt1KjurY%3D
38. SA Kliewer JM Lenhard TM Willson I Patel DC Morris JM Lehmann 1995 A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation Cell 83 813 819 8521498 10.1016/0092-8674(95)90194-9 1:CAS:528:DyaK2MXpvVehtb4%3D (Pubitemid 3006325)
39. T Kadowaki T Yamauchi N Kubota K Hara K Ueki K Tobe 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 1784 1792 16823476 10.1172/JCI29126 1:CAS:528:DC%2BD28XmvV2ltL0%3D (Pubitemid 44033298)
40. TP Combs JA Wagner J Berger, et al. 2002 Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization Endocrinology 143 998 1007 11861525 10.1210/en.143.3.998 1:CAS:528:DC%2BD38XhvVeis7o%3D (Pubitemid 34164048)